| 标题 |
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial |
| 网址 | |
| DOI |
10.1016/s0140-6736(23)01554-4
doi
|
| 其它 |
期刊:The Lancet 作者:Richard Lafayette; Jens Kristensen; Andrew Stone; Jürgen Floege; Vladimı́r Tesař; et al 出版日期:2023-08-14 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)